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Background: In patients with possible acute coronary syndrome (ACS) and negative cardiac biomarkers, recent unstable angina (USA) guidelines 
have recommended risk stratification with pharmacological stress myocardial perfusion imaging in acute chest pain who are unable to exercise or 
who have an abnormal resting ECG. The prognostic value of pre-discharge adenosine stress gated single photon computed tomography myocardial 
perfusion imaging (GSPECT) has not been assessed.
Methods: 1,564 patients with acute chest pain (normal ecg and cardiac biomarkers) were evaluated prospectively at a tertiary care hospital’s 
observational unit. Adenosine GSPECT (single day protocol) was performed within 24 hours of admission with quantification of total left ventricular 
perfusion defect size (PDS). Follow-up for the coronary events of cardiac death (CD), myocardial infarction (MI) and/or USA was performed at 6 
months.
Results: Baseline demographics include: mean age 55.5 ± 13.8, male 41.8%, HTN 62.2%, DM 15.5%, dyslipidemia 39.8%, CAD 11.7%, meanTIMI 
score 1.7 ± 0.9. An abnormal scan result was present in 133 patients (8.5%), of whom 83 (5.3%) had a reversible perfusion defect. Mean follow-up 
was 7.3 ± 2.8 months. Cardiac events occurred in 58 (3.7%) patients: CD (n = 1, 0.06%), nonfatal acute MI (n = 11, 0.7%), USA (n = 46, 2.9%). 
Total event rates increased stepwise with increasing PDS: PDS=0 1.3% (n=19), PDS=1-15 22.2% (n=18), PDS>15 40.4% {(n=21), p < 0.001}.
Conclusions: Adenosine GSPECT provides powerful prognostic risk assessment in acute chest pain patients. The use of adenosine stress GSPECT is 
consistent with the recommended use of pharmacological stress testing in published clinical practice guidelines.
